These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line. Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase. Hernick M; Flader C; Borch RF J Med Chem; 2002 Aug; 45(16):3540-8. PubMed ID: 12139465 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological activity of 5-fluoro-2'-deoxyuridine 5'-phosphorodiamidates. Phelps ME; Woodman PW; Danenberg PV J Med Chem; 1980 Nov; 23(11):1229-32. PubMed ID: 6779007 [TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationship of uridine-based nucleoside phosphoramidate prodrugs for inhibition of dengue virus RNA-dependent RNA polymerase. Wang G; Lim SP; Chen YL; Hunziker J; Rao R; Gu F; Seh CC; Ghafar NA; Xu H; Chan K; Lin X; Saunders OL; Fenaux M; Zhong W; Shi PY; Yokokawa F Bioorg Med Chem Lett; 2018 Jul; 28(13):2324-2327. PubMed ID: 29801997 [TBL] [Abstract][Full Text] [Related]
28. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU. Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484 [TBL] [Abstract][Full Text] [Related]
29. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition. Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504 [TBL] [Abstract][Full Text] [Related]
30. A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes. Liao ZY; Sordet O; Zhang HL; Kohlhagen G; Antony S; Gmeiner WH; Pommier Y Cancer Res; 2005 Jun; 65(11):4844-51. PubMed ID: 15930305 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts. Liu C; Willingham M; Liu J; Gmeiner WH Int J Oncol; 2002 Aug; 21(2):303-8. PubMed ID: 12118325 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2'-deoxyuridine and 2',5-difluoro-2'-deoxyuridine as potential dual action anticancer prodrugs. Xia Z; Wiebe LI; Miller GG; Knaus EE Arch Pharm (Weinheim); 1999 Aug; 332(8):286-94. PubMed ID: 10489539 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel 2',3'-didehydro-2',3'-dideoxyinosine phosphoramidate prodrugs and evaluation of their anticancer activity. Borek W; Lewandowska M; Kleczewska N; Ruszkowski P; Kacprzak K; Celewicz L Nucleosides Nucleotides Nucleic Acids; 2014; 33(8):507-18. PubMed ID: 25009986 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological activity of a gemcitabine phosphoramidate prodrug. Wu W; Sigmond J; Peters GJ; Borch RF J Med Chem; 2007 Jul; 50(15):3743-6. PubMed ID: 17602464 [TBL] [Abstract][Full Text] [Related]
36. Genetic complementation and resistance to 5-fluoro-2'-deoxyuridine in thymidine auxotrophs expressing a highly defective mutant of human thymidylate synthase. Zapf JW; Zhao PS; Steadman DJ; Berger SH Biochem Pharmacol; 1999 Sep; 58(6):973-81. PubMed ID: 10509749 [TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of phosphotyrosine peptidomimetic prodrugs. Garrido-Hernandez H; Moon KD; Geahlen RL; Borch RF J Med Chem; 2006 Jun; 49(11):3368-76. PubMed ID: 16722656 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and anti-herpetic activity of phosphoramidate ProTides. Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629 [TBL] [Abstract][Full Text] [Related]
39. A novel approach to thymidylate synthase as a target for cancer chemotherapy. Li Q; Boyer C; Lee JY; Shepard HM Mol Pharmacol; 2001 Mar; 59(3):446-52. PubMed ID: 11179438 [TBL] [Abstract][Full Text] [Related]
40. Enhancement of nucleoside cytotoxicity through nucleotide prodrugs. Rose JD; Parker WB; Someya H; Shaddix SC; Montgomery JA; Secrist JA J Med Chem; 2002 Sep; 45(20):4505-12. PubMed ID: 12238929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]